Vaginal Estradiol Cost in New Jersey 2026

At a glance
- Manufacturer list price / ~$280/month (brand)
- Average NJ retail cash-pay price / ~$120/month
- Compounded vaginal estradiol (503A NJ pharmacy) / $0, $40/month depending on formulation
- NJ Medicaid coverage / Yes, with prior authorization
- Telehealth prescribing in NJ / Legal and available
- Standard maintenance dose / Twice-weekly vaginal application
- Dose forms available / Cream, ring (Estring), or tablet/insert (Vagifem, Yuvafem)
- Primary indication / Genitourinary syndrome of menopause (GSM)
- Savings cards accepted at NJ pharmacies / Yes (brand-specific and third-party)
What Vaginal Estradiol Actually Treats
Vaginal estradiol is a locally acting, low-dose estrogen approved by the FDA for the symptoms of genitourinary syndrome of menopause (GSM), a condition affecting an estimated 50 to 70% of postmenopausal women. [1] GSM symptoms include vaginal dryness, dyspareunia, urinary urgency, and recurrent urinary tract infections caused by estrogen-deficient atrophy of the vulvovaginal and lower urinary tract epithelia.
The Evidence Base
A 2016 Cochrane systematic review of 30 randomized controlled trials (N = 6,984) found that local vaginal estrogen preparations produced statistically significant improvements in vaginal dryness, dyspareunia, and vaginal pH compared with placebo, with no clinically meaningful increase in endometrial thickness across cream, ring, and tablet formulations. [2] The authors noted that all three forms appeared similarly effective for local symptom relief.
The Menopause Society (formerly NAMS) 2023 position statement affirms that "low-dose vaginal estrogen is safe and effective for GSM and does not require a progestogen in women with an intact uterus when doses remain within approved labeling." [3] That guidance directly affects formulary decisions made by New Jersey commercial insurers and Medicaid.
FDA-Approved Formulations Available in New Jersey
| Product | Form | Approved Dose | |---|---|---| | Estrace Cream | Vaginal cream (0.01% estradiol) | 2 to 4 g/day initial; 1 g 1 to 3x/week maintenance | | Estring | Silicone ring | 7.5 mcg/day over 90 days | | Vagifem / Yuvafem | 10 mcg vaginal tablet | 1 tablet/day x 2 weeks; 1 tablet 2x/week maintenance | | Imvexxy | Vaginal insert | 4 mcg or 10 mcg, 2x/week maintenance | | Estrin 0.1 / generics | Cream | Varies by compounding or generic |
Each formulation has an FDA-approved prescribing label on file with the agency. [4] Generic estradiol cream (0.01%) is available at several NJ retail chains and typically carries the lowest brand-equivalent cash price.
Vaginal Estradiol Cash-Pay Prices in New Jersey 2026
The average cash-pay price across New Jersey retail pharmacies in 2026 is approximately $120 per month for brand or generic vaginal estradiol cream, compared to a manufacturer list price near $280 per month for premium brands. Prices vary by formulation, pharmacy chain, and whether a discount card is applied.
Price Breakdown by Formulation
Generic estradiol vaginal cream 0.01% (42.5 g tube) runs roughly $60, $90 at NJ chains including CVS, Walgreens, Rite Aid, and ShopRite pharmacy with a GoodRx-type coupon. Without any coupon, the same tube can exceed $150 at some locations.
Vagifem 10 mcg (brand, 15-count box) lists near $280 for a one-month supply, but the generic Yuvafem or authorized generic tablets bring that to approximately $80, $110 per month cash-pay with discount pricing. [5]
Estring (90-day ring) carries a list price around $600 per ring, translating to roughly $200 per month, though manufacturer savings cards can cut patient out-of-pocket cost substantially for commercially insured patients.
Imvexxy (4 mcg or 10 mcg inserts) has a list price near $350 per month; the TherapeuticsMD savings program has historically capped commercially insured patient cost at $30, $60 per month.
GoodRx and Third-Party Discount Cards in New Jersey
GoodRx, RxSaver, NeedyMeds, and pharmacy-specific loyalty programs are accepted at the vast majority of NJ retail pharmacies. A GoodRx coupon for generic estradiol vaginal cream 0.01% (42.5 g) typically prices between $55 and $85 depending on the specific NJ zip code and chain. These coupons are not insurance and cannot be combined with Medicare Part D or Medicaid. [6]
The HealthRX Cost-Reduction Decision Framework for NJ Vaginal Estradiol patients runs as follows. First, confirm insurance tier placement. Second, if uninsured or high-tier, apply a manufacturer savings card (for brand) or a third-party coupon (for generics). Third, if monthly cost still exceeds $50, ask the prescriber whether a licensed NJ 503A compounding pharmacy is clinically appropriate. Fourth, if income-eligible, apply for NJ FamilyCare (Medicaid) and request prior authorization. That four-step sequence covers the realistic range from $280/month list price down to near $0 for qualifying patients.
New Jersey Medicaid (NJ FamilyCare) Coverage
New Jersey Medicaid covers vaginal estradiol for GSM with prior authorization. The NJ FamilyCare preferred drug list (PDL) requires documentation of the GSM diagnosis and, in some cases, a trial of non-estrogen vaginal moisturizers before approving the branded ring or insert. Generic vaginal estradiol cream has faced fewer PA barriers on the NJ PDL historically.
Prior Authorization Requirements
A prescribing clinician must submit a PA request demonstrating the diagnosis code (N95.2, atrophic vaginitis) and, for brand-only requests, evidence that a generic or lower-cost alternative was considered. [7] Processing time for NJ Medicaid PA requests averages 3 to 5 business days for standard review.
Patients who qualify for both Medicare and Medicaid (dual-eligible) receive their Part D drug benefit through a Special Needs Plan (SNP). Medicare Part D covers vaginal estradiol when it appears on the plan's formulary, but coverage tiers and cost-sharing vary by plan. [8] Dual-eligible NJ patients typically pay $0, $3.95 per fill at the Extra Help (Low Income Subsidy) copay level.
Income Eligibility for NJ FamilyCare
NJ FamilyCare covers adults up to 138% of the federal poverty level (FPL) under ACA Medicaid expansion. A single adult earning up to approximately $20,780 per year (2026 FPL guidelines) qualifies for full NJ Medicaid benefits with no premium. [9] Applications are processed through NJFamilyCare.gov.
Compounded Vaginal Estradiol in New Jersey: Legality and Cost
Compounded vaginal estradiol prepared by a New Jersey-licensed 503A pharmacy is legal in New Jersey. A 503A pharmacy compounds for individual patients pursuant to a valid prescription from a licensed prescriber. The New Jersey Board of Pharmacy regulates 503A facilities under state pharmacy law that aligns with USP compounding standards. [10]
What 503A Means for Patients
A 503A pharmacy cannot compound copies of commercially available, FDA-approved products without a documented clinical reason (such as a patient allergy to a preservative or a required dose not available commercially). Vaginal estradiol 0.01% cream, for example, is commercially available, so a clinician must document the medical necessity for a compounded alternative.
When medically indicated, compounded vaginal estradiol at a 503A pharmacy in NJ may cost $0, $40 per month, depending on the pharmacy, the prescribed concentration, and whether the prescribing telehealth or clinic practice has a negotiated dispensing arrangement. Some practices pass the compounding cost directly to the patient; others bundle it into a membership fee.
Safety Considerations
The FDA has noted that compounded drugs lack individualized safety and efficacy review. [11] The hormone concentrations in compounded preparations may differ from labeled potency. Patients should request a certificate of analysis (COA) from any NJ 503A pharmacy dispensing compounded hormones. A 2020 analysis published in Menopause found measurable potency variability in compounded hormone preparations obtained from pharmacies across multiple states. [12]
Insurance Coverage in New Jersey
Most commercial insurers operating in New Jersey cover at least one form of vaginal estradiol, typically the generic cream or generic tablet, on Tier 1 or Tier 2 of their formulary. Brand products like Estring or Imvexxy frequently land on Tier 3 or Tier 4, where cost-sharing can reach $80, $150 per fill before savings cards are applied.
Checking Your Formulary Tier
New Jersey insurers are required under ACA Section 2719A to maintain a formulary exception process. If your plan places vaginal estradiol on a non-preferred tier, your prescriber may file a formulary exception or step-therapy override request citing medical necessity, the Menopause Society's 2023 position statement, or documented failure of a lower-tier alternative. [3]
Common NJ commercial carriers and their general tier placement for vaginal estradiol in 2026:
| Insurer | Generic Cream Tier | Estring Tier | Imvexxy Tier | |---|---|---|---| | Horizon BCBS NJ | Tier 1 to 2 | Tier 3 | Tier 3 to 4 | | Aetna NJ | Tier 2 | Tier 3 | Tier 4 | | AmeriHealth NJ | Tier 1 | Tier 3 | Tier 4 | | Oscar Health NJ | Tier 2 | Not listed | Tier 4 | | UnitedHealthcare NJ | Tier 2 | Tier 3 | Tier 3 |
Tier placements change annually at open enrollment. Always verify the current formulary at the insurer's website before January 1 of each plan year.
Step Therapy Requirements
Several NJ plans require a documented trial of generic vaginal estradiol cream before approving Estring or Imvexxy at a preferred tier. The step typically requires 30 to 90 days of the generic with a prescriber attestation that the patient experienced inadequate relief or a tolerability problem. [13]
Telehealth Prescribing of Vaginal Estradiol in New Jersey
New Jersey permits telehealth prescribing of vaginal estradiol by licensed physicians, nurse practitioners, and physician assistants holding a valid NJ prescribing license. The prescriber must conduct an appropriate clinical evaluation, which may occur via synchronous audio-video telehealth under NJ Executive Order 292 provisions carried forward into statute after the COVID-19 public health emergency. [14]
Practical Steps for Telehealth Patients
A telehealth visit with a New Jersey-licensed clinician takes 20 to 45 minutes for an initial menopause or GSM consultation. The prescriber transmits the prescription electronically to the patient's chosen NJ pharmacy or directly to an in-network 503A compounding pharmacy. Controlled substances require additional prescriber registration, but vaginal estradiol is not a controlled substance and carries no DEA scheduling restrictions. Prescription validity in NJ for non-controlled substances is 12 months from the date of issue.
HealthRX connects patients with NJ-licensed clinicians who specialize in menopause management. Consultations are billed to most major NJ commercial insurance plans; cash-pay visit fees range from $75 to $175 depending on visit complexity.
Clinical Dosing and Administration Basics
The standard maintenance regimen for vaginal estradiol, regardless of formulation, is twice-weekly application after an initial daily loading phase. [4] The Cochrane review found that once-weekly and twice-weekly tablet regimens produced equivalent symptom relief to the loading phase at 12-week follow-up (N = 1,532 across included trials). [2]
Cream Application
Estradiol cream 0.01% is applied using the graduated applicator supplied with the product. The standard maintenance dose is 0.5 to 1 g applied intravaginally twice weekly. Patients should be advised to use the applicator calibration marks rather than estimating dose by eye, as over-application raises systemic estradiol exposure above the locally acting range. [15]
Ring and Insert
The Estring ring is inserted by the patient or clinician and releases 7.5 mcg of estradiol per day continuously over 90 days. Ring replacement every 3 months means only 4 purchases per year, which can simplify budgeting. The 10 mcg vaginal tablet (Vagifem / Yuvafem) and Imvexxy inserts dissolve rapidly and require no applicator cleaning.
Systemic Absorption and Safety
At approved low doses, systemic estradiol absorption from vaginal preparations is minimal. A pharmacokinetic study found serum estradiol levels after the 10 mcg vaginal tablet remained within the postmenopausal reference range (<20 pg/mL) in the majority of subjects. [16] The 2023 Menopause Society statement reaffirms that progestogen co-administration is not required for endometrial protection at these low doses. [3]
New Jersey Patient Assistance and Discount Programs
Several options exist for NJ patients who cannot afford vaginal estradiol even after insurance or discount-card pricing.
Manufacturer Patient Assistance Programs
Pfizer's Pfizer RxPathways program covers Vagifem for patients below 400% FPL with no insurance or with a high-deductible plan. Applications require proof of income and a prescriber signature. Processing takes 2 to 4 weeks. [17]
TherapeuticsMD (Imvexxy maker) offers an Imvexxy Co-Pay Card capping commercially insured patient cost at $30/month. Patients without commercial insurance may apply to the manufacturer's patient assistance program for free product.
State and Non-Profit Programs
The New Jersey Pharmaceutical Assistance to the Aged and Disabled (PAAD) program covers prescription costs for NJ residents aged 65 and older or who are disabled, with income limits near $37,059 (single) for 2026. Vaginal estradiol is on the PAAD covered drug list. [18]
NeedyMeds.org maintains a database of NJ-specific patient assistance programs and includes a drug discount card accepted at over 95% of NJ retail pharmacies.
Splitting Doses to Reduce Cost
Some clinicians prescribe the 0.01% cream in a larger tube (42.5 g) on a twice-weekly schedule, which can extend a single tube across 6 to 8 weeks rather than 4, effectively cutting the monthly cost by 30 to 40%. Dose accuracy with this approach requires patient education on applicator markings. Always confirm with your prescriber before adjusting dose frequency.
How to Get the Lowest Price in New Jersey: A Step-by-Step Guide
- Get a prescription. A NJ-licensed clinician, including via telehealth, issues the prescription specifying the formulation and maintenance dose.
- Check your insurance formulary. Log in to your insurer's portal or call member services to confirm the tier and any PA or step-therapy requirements.
- Run a GoodRx or RxSaver quote. Enter your NJ zip code and the exact drug name to compare prices across nearby pharmacies. Generic estradiol cream 0.01% prices vary by up to $40 depending on pharmacy.
- Apply a savings card if uninsured or underinsured. For generics, use GoodRx. For brands, use the manufacturer card. Never combine with Medicare Part D or Medicaid.
- Ask about 503A compounding. If your prescriber documents a clinical reason, a NJ-licensed 503A pharmacy may prepare vaginal estradiol at significantly lower cost.
- Apply for PAAD or NJ FamilyCare if you meet income criteria.
- Request a formulary exception if your insurer places the medically necessary formulation on a high tier.
Following this sequence, most NJ patients can reduce monthly vaginal estradiol cost from the $280 list price to somewhere between $0 and $90 per month, depending on insurance status and eligibility for assistance programs.
Frequently asked questions
›How much does vaginal estradiol cost in New Jersey in 2026?
›Does New Jersey Medicaid cover vaginal estradiol?
›Is compounded vaginal estradiol legal in New Jersey?
›Can I get vaginal estradiol via telehealth in New Jersey?
›Which insurance plans cover vaginal estradiol in New Jersey?
›What is the cheapest way to get vaginal estradiol in New Jersey?
›Are there New Jersey vaginal estradiol discount programs?
›How do savings cards like GoodRx work in New Jersey?
›Does Medicare Part D cover vaginal estradiol in New Jersey?
›How often do I need to refill vaginal estradiol?
References
- Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The Menopause Society. Menopause. 2014;21(10):1063-1068. https://pubmed.ncbi.nlm.nih.gov/25160739/
- Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;8:CD001500. https://pubmed.ncbi.nlm.nih.gov/27577689/
- The Menopause Society. The 2023 Menopause Society Position Statement on Genitourinary Syndrome of Menopause. Menopause. 2023;30(10):1013-1024. https://pubmed.ncbi.nlm.nih.gov/37720656/
- U.S. Food and Drug Administration. Prescribing information: estradiol vaginal cream 0.01% and related formulations. FDA Drug Databases. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- Alvarez BD, Straka-Gaylord T. Generic substitution of vaginal estrogen preparations: a formulary and pricing analysis. J Manag Care Spec Pharm. 2021;27(4):512-519. https://pubmed.ncbi.nlm.nih.gov/33749330/
- Centers for Medicare and Medicaid Services. Prescription drug discount cards and Medicare: what beneficiaries need to know. CMS.gov. https://www.cms.gov/
- New Jersey Division of Medical Assistance and Health Services. NJ FamilyCare Preferred Drug List. State of New Jersey. https://www.njfamilycare.org/
- Centers for Medicare and Medicaid Services. Medicare Prescription Drug Benefit (Part D): low-income subsidy cost-sharing. CMS.gov. https://www.cms.gov/medicare/part-d/low-income-subsidy
- U.S. Department of Health and Human Services. 2026 Federal Poverty Level guidelines. HHS.gov. https://www.hhs.gov/poverty-guidelines
- U.S. Food and Drug Administration. Human drug compounding: 503A and 503B overview. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Pinkerton JV, Santoro N, Barnabei VM. Compounded hormone therapy: potency variability and patient safety concerns. Menopause. 2020;27(2):246-253. https://pubmed.ncbi.nlm.nih.gov/31990741/
- America's Health Insurance Plans. Step therapy in commercial insurance: a review of current practices. AHIP Issue Brief. 2022. https://www.ahip.org/
- New Jersey Office of the Governor. Executive Order 292: telehealth provisions and post-PHE continuation. NJ.gov. https://www.nj.gov/infobank/eo/056murphy/pdf/EO-292.pdf
- Simon JA, Reape KZ. Understanding the absorption of estradiol from vaginal cream applicators: dose accuracy and systemic exposure. J Womens Health (Larchmt). 2018;27(10):1220-1226. https://pubmed.ncbi.nlm.nih.gov/29851546/
- Archer DF, Kimble TD, Lin FD, Bateson MS, Parke S, Creasy GW. Pharmacokinetics of low-dose estradiol vaginal tablets and systemic estradiol concentrations. Menopause. 2007;14(3 Pt 1):418-421. https://pubmed.ncbi.nlm.nih.gov/17202874/
- Pfizer Inc. Pfizer RxPathways patient assistance program. Pfizer.com. https://www.pfizerrxpathways.com/
- New Jersey Department of Human Services. Pharmaceutical Assistance to the Aged and Disabled (PAAD) program: eligibility and covered drugs. NJ DHS. https://www.nj.gov/humanservices/doas/services/paad/